zilovertamab vedotin,Gemcitabine,Oxaliplatin,rituximab
merck
['cml']
#17icml antiror1 asc. zikovertamab vesotin. 18% of crr as single agent.
new treatment player on coming. 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166